Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 34, Issue 10, Pages 2281-2285
Publisher
Oxford University Press (OUP)
Online
2013-05-23
DOI
10.1093/carcin/bgt176
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LINE-1 Hypomethylation in Noncancerous Esophageal Mucosae is Associated with Smoking History
- (2012) Hironobu Shigaki et al. ANNALS OF SURGICAL ONCOLOGY
- Androgens, diabetes and prostate cancer
- (2012) Mathis Grossmann et al. ENDOCRINE-RELATED CANCER
- Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
- (2012) Fritz H. Schröder et al. EUROPEAN UROLOGY
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
- (2012) G. L. Andriole et al. JNCI-Journal of the National Cancer Institute
- Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml
- (2012) Giuseppe Lucarelli et al. PROSTATE
- GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization
- (2011) Hao Wu et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- A Reproducible and High-Throughput HPLC/MS Method To Separate Sarcosine from α- and β-Alanine and To Quantify Sarcosine in Human Serum and Urine
- (2011) Tamra E. Meyer et al. ANALYTICAL CHEMISTRY
- Smoking and Prostate Cancer Survival and Recurrence
- (2011) Stacey A. Kenfield JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Is sarcosine a biomarker for prostate cancer?
- (2011) Haleem J. Issaq et al. JOURNAL OF SEPARATION SCIENCE
- Metabolite profiles and the risk of developing diabetes
- (2011) Thomas J Wang et al. NATURE MEDICINE
- Serum Methionine Metabolites Are Risk Factors for Metastatic Prostate Cancer Progression
- (2011) Sally Stabler et al. PLoS One
- Metabolomic Profiling Reveals a Role for Androgen in Activating Amino Acid Metabolism and Methylation in Prostate Cancer Cells
- (2011) Nagireddy Putluri et al. PLoS One
- LINE-1 Methylation Levels in Leukocyte DNA and Risk of Renal Cell Cancer
- (2011) Linda M. Liao et al. PLoS One
- Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine
- (2011) D-L Cao et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Association between C-Peptide Concentration and Prostate Cancer Incidence in the CLUE II Cohort Study
- (2010) G. Y. Lai et al. Cancer Prevention Research
- Is Urinary Sarcosine Useful to Identify Patients With Significant Prostate Cancer? The Trials and Tribulations of Biomarker Development
- (2010) Jack A. Schalken EUROPEAN UROLOGY
- Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours. Eur Urol 2010;58:12–8
- (2010) Arun Sreekumar et al. EUROPEAN UROLOGY
- Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours. Eur Urol 2010;58:12–8
- (2010) Daniela Colleselli et al. EUROPEAN UROLOGY
- Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in Urine After Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours. Eur Urol 2010;58:12–8
- (2010) Amitha K Hewavitharana EUROPEAN UROLOGY
- Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours
- (2010) Florian Jentzmik et al. EUROPEAN UROLOGY
- Sarcosine in Prostate Cancer Tissue is Not a Differential Metabolite for Prostate Cancer Aggressiveness and Biochemical Progression
- (2010) Florian Jentzmik et al. JOURNAL OF UROLOGY
- A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer
- (2010) Da-Long Cao et al. PROSTATE
- Serum sarcosine is not a marker for prostate cancer
- (2010) E. A. Struys et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Cigarette Smoking and Prostate Cancer in a Prospective US Cohort Study
- (2009) J. L. Watters et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
- (2009) Arun Sreekumar et al. NATURE
- Hormonal profile of diabetic men and the potential link to prostate cancer
- (2008) Jocelyn S. Kasper et al. CANCER CAUSES & CONTROL
- Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
- (2008) Michael F. Leitzmann et al. CANCER CAUSES & CONTROL
- Endogenous sex hormones and the risk of prostate cancer: A prospective study
- (2008) Jocelyn M. Weiss et al. INTERNATIONAL JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started